| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |